Abstract
In this article, the composition and technology of combined eye drops were developed, including taurine as an anti-cataract agent and betaxolol hydrochloride as an anti-glaucoma agent. Butanol, toluene, isopropyl ether, chloroform, ammonia 25%, ethyl alcohol in various ratios were used as the mobile phase. However, these solutions and their combinations did not allow us to determine a system that makes it possible to register both active components simultaneously. Therefore, it was decided to select two thin layer chromatography systems, one of which made it possible to determine taurine, and the other betaxolol hydrochloride
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
